Author:
Kendre P. N,Chaudhari P. D.,
Abstract
Present study involves the design and optimization of oral bioadhesive delivery system of curcumin. Solid dispersion of curcumin was developed using novel hydrophilic carrier, Gelucire® 50/13, by melt granulation technique. Based on HPMC K 100 LV(X1) and carbopol 934P (X2), bio-adhesive tablets containing curcumin solid dispersion was developed by direct compression, using central composite designs for two factors at three levels. Tablet formulation was optimized for t50%, Rel24h and bioadhesive strength. The drug release mechanism was found to be by fickian diffusion, approaching zero-order kinetics. Average plasma uptake of curcumin was found to be 0.289μg/mL as compared to plain curcumin tablet formulation. The results were found highly significant (p<0.05). The swelling matrices behavior over the time period studied showed that the gelling layer thickness increases continuously. From this study, it may be concluded that the oral controlled bioadhesive curcumin delivery may be an alternative to parenteral chemotherapy.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference33 articles.
1. 1. Mukerje A., Vishwanatha J.K.: Formulation Characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res., 2009, 29,3867-3876
2. 2. Thanki K., Gangwal R.P., Sangamwar A, Jain S.: Oral drug delivery of anticancer drugs: challenges and opportunities, J. Controlled Rel., 2013,170,15-40
3. 3. Srinivasan K.R., The colouring matter in turmeric. Curr Sci. 1952,311
4. 4. Anand P, Kunnumakkara A.B., Newman R.A., Aggarwal B.B.: Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, 4,807-818
5. 5. Lao C.D., Ruffin M.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., Boggs M.E., Crowell J., Rock C.L., Brenner D.E.: Dose escalation of a curcuminoid formulation. BMC Complement Altern. Med., 2006,17,6-10